13,14-dihydro-15-keto-tetranor Prostaglandin F1α (Synonyms: 5β, 7αdihydroxy11ketotetranorProstanoic Acid, 9β13,14dihydro15ketotetranor Prostaglandin F1α, 9β,11αdihydroxy15oxo2,3,4,5tetranorProstanoic Acid) |
| カタログ番号GC41903 |
Fシリーズプロスタグランジン（PG）の代謝は、一般的にC-13とC-14の二重結合の還元と、C-15のヒドロキシル基の酸化から始まり、13,14-ジヒドロ-15-ケトPGを生成します。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 24379-94-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
The metabolism of F series prostaglandins (PGs), including PGF1α and PGF2α, commonly begins with the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω carbon produces the abundant urinary metabolites, including tetranor-PGFM. 13,14-dihydro-15-keto tetranor PGF1α is a potential metabolite of either PGF1α or PGF2α and likely precursor to tetranor-PGFM.
Average Rating: 5 (Based on Reviews and 22 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *